Literature DB >> 12079766

The special nature of human walking and its neural control.

Charles Capaday1.   

Abstract

Walking the way we do is inherently unstable. Sophisticated neurological control systems are required to ensure that we progress and maintain our balance at the same time. Most of what is known about the functional organization of these neurological control systems is inferred from studies on animals. Here, I compare selected studies on the neural control of human walking with similar studies in reduced animal preparations. The simple monosynaptic reflex appears to be controlled by comparable mechanisms in walking cats and humans. However, peripheral feedback mechanisms suggested to contribute to the switch from stance to swing on the basis of experiments in reduced cat preparations have little influence during human walking. A cat whose spinal cord has been completely transected can be made to walk on a treadmill by drug injections, but such an immediate effect of pharmacological intervention is not seen in humans. However, there have been reports that pharmacological intervention can improve the walking of patients with incomplete spinal cord injury, especially when pharmacological treatment is combined with training.

Entities:  

Mesh:

Year:  2002        PMID: 12079766     DOI: 10.1016/s0166-2236(02)02173-2

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  56 in total

1.  Reflex and non-reflex torque responses to stretch of the human knee extensors.

Authors:  N Mrachacz-Kersting; T Sinkjaer
Journal:  Exp Brain Res       Date:  2003-04-18       Impact factor: 1.972

2.  Gait biomechanics, spatial and temporal characteristics, and the energy cost of walking in older adults with impaired mobility.

Authors:  David M Wert; Jennifer Brach; Subashan Perera; Jessie M VanSwearingen
Journal:  Phys Ther       Date:  2010-05-20

Review 3.  The influence of orthosis options on walking parameters in spinal cord-injured patients: a literature review.

Authors:  M Arazpour; M Samadian; K Ebrahimzadeh; M Ahmadi Bani; S W Hutchins
Journal:  Spinal Cord       Date:  2016-02-09       Impact factor: 2.772

4.  Impact of exercise to improve gait efficiency on activity and participation in older adults with mobility limitations: a randomized controlled trial.

Authors:  Jessie M VanSwearingen; Subashan Perera; Jennifer S Brach; David Wert; Stephanie A Studenski
Journal:  Phys Ther       Date:  2011-10-14

5.  Coordinated modulation of locomotor muscle synergies constructs straight-ahead and curvilinear walking in humans.

Authors:  Grégoire Courtine; Charalambos Papaxanthis; Marco Schieppati
Journal:  Exp Brain Res       Date:  2005-11-19       Impact factor: 1.972

6.  Walking performance and its recovery in chronic stroke in relation to extent of lesion overlap with the descending motor tract.

Authors:  H Dawes; C Enzinger; H Johansen-Berg; M Bogdanovic; C Guy; J Collett; H Izadi; C Stagg; D Wade; P M Matthews
Journal:  Exp Brain Res       Date:  2007-12-21       Impact factor: 1.972

7.  An analytical formulation of the law of intersegmental coordination during human locomotion.

Authors:  Avi Barliya; Lars Omlor; Martin A Giese; Tamar Flash
Journal:  Exp Brain Res       Date:  2008-11-26       Impact factor: 1.972

8.  Motor learning versus standard walking exercise in older adults with subclinical gait dysfunction: a randomized clinical trial.

Authors:  Jennifer S Brach; Jessie M Van Swearingen; Subashan Perera; David M Wert; Stephanie Studenski
Journal:  J Am Geriatr Soc       Date:  2013-10-28       Impact factor: 5.562

9.  A unifying model for timing of walking onset in humans and other mammals.

Authors:  Martin Garwicz; Maria Christensson; Elia Psouni
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

10.  Ankle dorsiflexion as an fMRI paradigm to assay motor control for walking during rehabilitation.

Authors:  Bruce H Dobkin; Ann Firestine; Michele West; Kaveh Saremi; Roger Woods
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.